Norges Bank’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-857,758
Closed -$6.85M 1963
2023
Q3
$6.85M Sell
857,758
-50,000
-6% -$502K ﹤0.01% 1598
2023
Q2
$9.99M Hold
907,758
﹤0.01% 1534
2023
Q1
$9.38M Sell
907,758
-232,126
-20% -$2.73M ﹤0.01% 1607
2022
Q4
$12.5M Hold
1,139,884
﹤0.01% 1486
2022
Q3
$17.7M Buy
1,139,884
+500,000
+78% +$11M ﹤0.01% 1268
2022
Q2
$14.7M Hold
639,884
﹤0.01% 1387
2022
Q1
$15.8M Sell
639,884
-70,000
-10% -$1.58M ﹤0.01% 1512
2021
Q4
$19.4M Buy
709,884
+369,380
+108% +$12.9M ﹤0.01% 1498
2021
Q3
$14.6M Buy
+340,504
New +$15.1M ﹤0.01% 1638

Other funds holding DH

Norges Bank's DH Position: Q4 2023 in Review

Norges Bank sold out of Definitive Healthcare (DH) in Q4 2023, closing a stake of 857,758 shares — an estimated $6.85M sold.

Norges Bank first reported a position in DH in Q3 2021 and held it in 9 quarters. The position peaked at $19.4M in Q4 2021. 138 funds tracked by Wall St. Rank hold DH as of Q4 2023.

  • Norges Bank reported no remaining Definitive Healthcare position as of Q4 2023 after selling out during the quarter.
  • Norges Bank sold 857,758 Definitive Healthcare shares in Q4 2023, an estimated $6.85M.
  • Norges Bank first reported a position in Definitive Healthcare in Q3 2021 and held it in 9 quarters.
  • Norges Bank's Definitive Healthcare position peaked at $19.4M in Q4 2021.
  • 138 funds tracked by Wall St. Rank held Definitive Healthcare as of Q4 2023.

Based on Norges Bank's 13F filing for Q4 2023, filed 9 Feb 2024.